The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
- PMID: 27640331
- PMCID: PMC5082554
- DOI: 10.1111/apt.13794
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
Abstract
Background: Age at presentation with primary biliary cholangitis (PBC) is associated with differential response to ursodeoxycholic acid (UDCA) therapy. Younger-presenting patients are less likely to respond to treatment and more likely to need transplant or die from the disease. PBC has a complex impact on quality of life (QoL), with systemic symptoms often having significant impact.
Aim: To explain the impact of age at presentation on perceived QoL and the inter-related symptoms which impact upon it.
Methods: Using the UK-PBC cohort, symptoms were assessed using the PBC-40 and other validated tools. Data were available on 2055 patients.
Results: Of the 1990 patients reporting a global PBC-QoL score, 66% reported good/neutral scores and 34% reported poor scores. Each 10-year increase in age at presentation was associated with a 14% decrease in risk of poor perceived QoL (OR = 0.86, 95% CI: 0.75-0.98, P < 0.05). All symptom domains were similarly age-associated (P < 0.01). Social dysfunction was the symptom factor with the greatest impact on QoL. Median (interquartile range) PBC-40 social scores for patients with good perceived QoL were 18 (14-23) compared with 34 (29-39) for those with poor QoL.
Conclusion: The majority of patients with primary biliary cholangitis do not feel their QoL is impaired, although impairment is reported by a sizeable minority. Age at presentation is associated with impact on perceived QoL and the symptoms impairing it, with younger patients being more affected. Social dysfunction makes the greatest contribution to QoL impairment, and it should be targeted in trials aimed at improving life quality.
© 2016 The Authors. Alimentary Pharmacology & Therapeutics Published by John Wiley & Sons Ltd.
Figures



References
-
- Lindor KD, Gershwin ME, Poupon R, et al Primary biliary cirrhosis. Hepatology 2009; 50: 291–308. - PubMed
-
- Griffiths L, Dyson JK, Jones DE. The new epidemiology of primary biliary cirrhosis. Semin Liver Dis 2014; 34: 318–28. - PubMed
-
- Beuers U, Boberg KM, Chazouilleres O, et al EASL practice guidelines on management of cholestatic liver diseases. J Hepatol 2009; 51: 237–67. - PubMed
-
- Poupon RE, Chretien Y, Chazouilleres O, Poupon R, Chwalow J. Quality of life in patients with primary biliary cirrhosis. Hepatology 2004; 40: 489–94. - PubMed
-
- Mells G, Pells G, Newton JL, et al The impact of primary biliary cirrhosis on perceived quality of life: the UK‐PBC National Study. Hepatology 2013; 58: 273–83. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases